Treatment outcome of patients with idiopathic sudden sensorineural hearing loss and concomitant benign paroxysmal positional vertigo.
- Author:
Haixiong ZHANG
;
Qing ZHANG
;
Dadao XU
;
Min XU
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Aged, 80 and over;
Benign Paroxysmal Positional Vertigo;
complications;
therapy;
Female;
Hearing Loss, Sudden;
complications;
therapy;
Humans;
Male;
Middle Aged;
Prognosis
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2014;28(16):1212-1214
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the treatment outcome of patients with idiopathic sudden sensorineural hearing loss (ISSHL) with concomitant benign paroxysmal positional vertigo (BPPV).
METHOD:Out of 252 ISSHL patients, 96 patients were diagnosed with complicating vertigo and examined using electronystagmography. All patients were divided into three groups, namely, ISSHL without vertigo group (n=156), ISSHL with non-BPPV vertigo group (n=70) and ISSHL with BPPV group (n=26). All patients received daily intravenous infusion of 200,000 U urokinase for 3 consecutive days and 100,000 U for 3 additional days. Concomitant medications included intravenous Ginkgo biloba leave compound and vitamin B6 and intramuscular vitamins B1 and B12 for 2 weeks. Twenty-six patients diagnosed with BPPV on electronystagmography positioning test also received canalith repositioning maneuver.
RESULT:Vertigo-associated symptoms completely resolved after canalith repositioning maneuver in ISSHL patients with complicating BPPV. With respect to post-treatment hearing, ISSHL patients without vertigo exhibited a similar improvement as compared to those with BPPV, while those with non-BPPV vertigo had a significantly less improvement than those without vertigo and with BPPV.
CONCLUSION:ISSHL patients with complicating BPPV exhibit a relatively favorable outcome with respect to hearing and vertigo-associated symptoms after medical and repositioning treatment.
